Advanced colon cancer is the leading cause of cancer-related death in young American men and the second highest worldwide. In the majority of these patients, as the cancer advances it metastasizes to ...

HepaRegeniX GmbH (“HepaRegeniX”), a clinical-stage biotech company advancing novel therapies for acute and chronic liver diseases, today announced the completion of the Phase Ib minor resection study ...

Resection of liver metastases is considered the only treatment with curative potential for patients with metastatic colorectal cancer to the liver (CRLM). However, only a minority of patients with ...

In patients with primary sclerosing cholangitis (PSC) and inflammatory bowel disease (IBD), liver transplantation was associated with a 34% reduction in the risk for colorectal neoplasia. However, 21% ...

Colorectal cancer is the fourth-most-common cancer in the U.S. and the second deadliest. One in 5 patients is diagnosed with metastatic disease, meaning the colorectal cancer has spread beyond the ...

Acoustic cluster therapy combined with chemotherapy showed a 29% tumor diameter reduction, compared to 7% with chemotherapy alone in colorectal liver metastases. The therapy uses PS101, activated by ...

JACKSONVILLE, Fla. — Liver transplants are becoming a new treatment option for certain colorectal cancer patients whose cancer has spread to their liver and are ineligible for other surgical options.

“Exelixis Announces U.S. FDA Accepted the New Drug Application for Zanzalintinib in Combination with an Immune Checkpoint ...